DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,042 filers reported holding DANAHER CORPORATION in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21,299,137 | +4.8% | 85,849 | +1.4% | 0.29% | +7.0% |
| Q2 2023 | $20,321,280 | -8.6% | 84,672 | -4.0% | 0.27% | -16.6% |
| Q1 2023 | $22,227,912 | -2.3% | 88,192 | +2.9% | 0.32% | -11.9% |
| Q4 2022 | $22,750,210 | +19.7% | 85,714 | +16.5% | 0.37% | +1.1% |
| Q3 2022 | $19,001,000 | +17.6% | 73,566 | +15.5% | 0.36% | +12.7% |
| Q2 2022 | $16,152,000 | -22.1% | 63,712 | -9.9% | 0.32% | -6.1% |
| Q1 2022 | $20,731,000 | -9.9% | 70,674 | +1.0% | 0.34% | -4.4% |
| Q4 2021 | $23,021,000 | +24.5% | 69,970 | +15.2% | 0.36% | +2.8% |
| Q3 2021 | $18,493,000 | +7.7% | 60,744 | -5.0% | 0.35% | +11.4% |
| Q2 2021 | $17,164,000 | +94.7% | 63,958 | +63.3% | 0.32% | +68.4% |
| Q1 2021 | $8,816,000 | +1.0% | 39,169 | -0.4% | 0.19% | -1.6% |
| Q4 2020 | $8,732,000 | +6.5% | 39,310 | +3.3% | 0.19% | -5.5% |
| Q3 2020 | $8,197,000 | +80.6% | 38,069 | +48.3% | 0.20% | +71.8% |
| Q2 2020 | $4,539,000 | – | 25,669 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |